A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass-Reference-Cited by-同舟云学术

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

Published:2009-01 Issue:1 Volume:112 Page:40-46
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Moore Richard G.,McMeekin D. Scott,Brown Amy K.,DiSilvestro Paul,Miller M. Craig,Allard W. Jeffrey,Gajewski Walter,Kurman Robert,Bast Robert C.,Skates Steven J.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference24 articles.

1. Management of the adnexal mass;Curtin;Gynecol. Oncol.,1994

2. A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?;Carney;Gynecol. Oncol.,2002

3. Misstaging of ovarian cancer;McGowan;Obstet. Gynecol.,1985

4. Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals;Paulsen;Int. J. Gynecol. Cancer,2006

5. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma;Engelen;Cancer,2006

Cited by 690 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum miRNA improves the accuracy of a multivariate index assay for triage of an adnexal mass;Gynecologic Oncology;2024-11

2. Prospective external validation of IOTA methods for classifying adnexal masses and retrospective assessment of two‐step strategy using benign descriptors and ADNEX model: Portuguese multicenter study;Ultrasound in Obstetrics & Gynecology;2024-09-04

3. British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

4. Machine-Learning Diagnostic Models for Ovarian Tumors;Heliyon;2024-09

5. Clinical value of ACR O-RADS combined with CA125 in the risk stratification of adnexal masses;Frontiers in Oncology;2024-08-30